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Cyclical  fluctuations  in  both  the  humoral  antibody  response  (1-6)  and  in  cell- 
mediated immunity (7-11) have been observed in several species after a single injection of 
persisting antigens. The possibility that these fluctuations reflect regulatory mechanisms 
operating within the immune system has been previously reviewed (12). The response in 
rabbits  to  a  single  intravenous  injection  of  aggregated  human  gamma  globulin 
~AHuIgG) a has  been  characterized  by the  successive  appearance  of peaks  of plaque- 
forming cells  (PFC} in the spleen and peripheral blood, separated by well-defined 8-day 
periods of decreased responsiveness (4). Although there is evidence in other systems for 
regulation of the immune response by circulating antibody, resulting in cyclical varia- 
tions  of antibody and  PFC  (2), the  8-day latent  period  in  rabbit  spleens  is  observed 
regardless of the dose of antigen injected or the amount of circulating antibody formed. 
Thus,  it  was  postulated  that  if antibody  played a  role  in  this  system,  the  antibody 
produced locally, at the site of PFC production, was the best candidate for exerting such 
precise control of the response (4). 
The amount of antibody produced to several  antigens has been shown to be 
enhanced in rabbits by simultaneous injection of antigen and lipopolysaccharide 
(LPS) (13,  14),  phytohemagglutinin (PHA) (14,  15),  or concanavalin A  (Con A) 
(14)  and by sublethal  irradiation  after injection of antigen  (14,  16). Therefore, 
the  effect  of these  treatments  on the  cyclical nature  of the  PFC  response  in 
rabbits  to  AHuIgG was  examined  to  determine  if their  ability  to  exert  an 
adjuvant effect was regulated in the same manner as the normal PFC response 
to  AHuIgG.  In  addition,  different  injection  regimens  have  been  used  in  an 
attempt to define the conditions essential for cycling. 
Materials  and  Methods 
Animals.  Male, New Zealand  White  rabbits,  3- to 4-mo old, were used throughout  these 
studies. 
Antigens.  AHuIgG was  prepared  from Cohn Fraction  II of human  sera,  provided by the 
American Red Cross National Fractionation Center with the partial support of National Institutes 
of Health  grant no. 13881 (HEM}. The IgG fraction was isolated by chromatography on DEAE- 
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cellulose by elution with 0.01  M phosphate buffer, pH 8.0.  Ammonium sulfate precipitation (35%) 
was  used  in purifying the  IgG fraction from  pooled  turkey  sera.  The precipitate  was  dialyzed 
against borate-buffered saline,  pH 8.2,  and the IgG fraction was isolated by filtration on G-200 
Sephadex,  essentially according to the method described by Benedict for purification of chicken 
immunoglobulin  (17).  Both  immunoglobulins were  aggregated  by  heating at  63°C  for  25  min 
followed by precipitation with 0.62 M sodium sulfate as previously described (18). 
Mitogens.  LPS from Escherichia coli K235 was generously supplied by Abbott Laboratories, 
North Chicago, Ill., through Dr. Floyd C.  McIntire, now at the School of Dentistry, University of 
Colorado  Medical  School,  Denver,  Colo.  Con  A  (lots 88  and 96),  three times crystallized,  was 
purchased  from  Miles  Laboratories,  Inc.,  Kankakee,  Ill.  PHA-P  (lots 598555  and  598766)  was 
purchased from Difco Laboratories,  Detroit,  Mich. 
Irradiation.  Irradiated rabbits were given a whole body dose of 500 R. They were restrained in 
a  Lucite chamber and placed  in a  Gamma  Cell  40 small animal irradiator (Atomic Energy  of 
Canada, Ltd., Ottawa, Canada) which contained a cesium-137 source emitting a central dose of 115 
R/min. 
Hemolytic Plaque Assay.  PFC were measured by a  modification (19) of the Jerne and Nordin 
hemolytic  plaque  assay  (20).  Cohn  Fraction  II  from  human  sera  or  the  ammonium  sulfate- 
precipitated  fraction  of turkey  sera  were  coupled  to  goat  erythrocytes  (Colorado  Serum  Co., 
Denver,  Colo.) by  1-ethyl-3-(3-dimethylamino-propyl) carbodiimide HCl  (Story Chemical Corp., 
Muskegon,  Mich.) for enumeration of PFC  to HuIgG or turkey IgG, respectively.  Indirect PFC 
were developed with an antiserum to rabbit IgG prepared in sheep. 
Antibody Analysis.  Circulating antibody levels were determined by a quantitative precipitin 
test  which measures the amount of '3'I-labeled antigen precipitated at equivalence by  1 ml of 
serum (21).  Amounts of antibody protein were calculated on the basis of an antibody to antigen 
(HuIgG) weight ratio at equivalence of 2.5. 
Results 
Effect of  LPS on Cycling.  A cyclical production of indirect PFC was observed 
in spleens of rabbits injected simultaneously with 2 mg AHuIgG and 10/~g LPS 
intravenously (Fig.  1). The kinetic pattern of the response, as assayed 5, 8, and 
13 days after injection, was similar to that in rabbits injected with antigen only, 
in which peak PFC were obtained on day 5 and several succeeding peaks were 
observed at 8-day intervals (4). However, injection of antigen and LPS resulted 
in an average sixfold enhancement of the first peak of PFC (day 5) compared to 
rabbits receiving antigen only. LPS had no apparent effect on the second peak 
(day 13) since it was of the same magnitude regardless of whether rabbits were 
injected with AHuIgG alone or with AHuIgG and LPS. Both groups of rabbits 
had minimal  splenic PFC on day 8. Precipitating antibody levels on day 8, the 
day of maximal titer,  were sixfold higher in rabbits injected with AHuIgG and 
LPS compared to rabbits injected with antigen only (565/~g antibody/ml and 87 
/~g antibody/ml, respectively). 
Effect of PHA on Cycling.  Simultaneous injection of 2 mg AHuIgG and  10 
mg PHA also resulted in a cyclical pattern of splenic PFC production to HuIgG 
(Fig.  2). Injection of PHA with antigen resulted in a  threefold enhancement of 
PFC  on day 5 compared  to rabbits  injected with AHuIgG only.  Precipitating 
antibody levels on day 8 reflected the differences observed in PFC on day 5, with 
fourfold higher antibody levels in rabbits injected with PHA and antigen com- 
pared  to  those  injected  with  antigen  alone  (302  /~g  antibody/ml  and  81  /~g 
antibody/ml, respectively). PFC in rabbits injected with AHuIgG and PHA did 
not decrease to levels as low as on day 8, as in rabbits injected with antigen only, 
although  the  percentage  decrease  from  day  5  levels  was  similar  in  the  two CAROLE  G.  ROMBALL  AND  WILLIAM  O.  WEIGLE 
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Fro. i.  Comparison of PFC  kinetics  in spleens of rabbits after a single  intravenous 
injection  of  2 mg AHulgG with,  or without, a simultaneous injection  of 10 pg LPS. Each 
point  represents  an average of  PFC values from 9 to 10  rabbits. 
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Fro. 2.  Comparison of PFC  kinetics  in spleens of rabbits after a single  intravenous 
injection  of  2 mg AHulgG with,  or without, a simultaneous injection  of  10 mg PHA. Each 
point  represents  an average of  PFC values from 9 to 10 rabbits. 
groups.  On day 13,  in contrast to results obtained with LPS, PFC levels were 
again  markedly enhanced  in rabbits  injected with PHA and antigen  as com- 
pared to rabbits injected with antigen only. 
Effect of Con A  on Cycling.  In contrast to the lack of effect of either LPS or 
PHA injected simultaneously with antigen on the kinetic pattern of PFC produc- 500  REGULATION  OF  CYCLICAL  RESPONSES 
tion to HuIgG in spleens of rabbits,  Con A injected under the same conditions 
disrupted  the  cyclical  appearance  of PFC  (Fig.  3).  Injection  of Con  A  with 
AHuIgG also caused an increase (approximately 1.5 times) in the total number 
of lymphocytes in  the  spleen  on  all  days tested  compared  to  the  number  of 
splenic lymphocytes in rabbits injected with AHuIgG only. Indirect PFC on day 
5  in  rabbits  injected  with  10  mg  Con  A  and  2  mg AHuIgG  were  depressed, 
compared to PFC in rabbits injected with antigen only. However, PFC (per 106 
spleen  cells)  showed  an  approximately  linear  increase  on  days  8  and  13  in 
rabbits injected with Con A and simultaneously with antigen, so that by day 13, 
PFC (per 106 spleen cells) were five times greater than in spleens from rabbits 
injected with antigen alone. On day 8, a time when minimal PFC were detected 
in rabbits injected with antigen only (less than 30 PFC per 106 spleen cells), an 
average of 160 PFC  per  106 spleen cells was detected in rabbits injected with 
Con A and 2 mg AHuIgG. Despite the marked difference in the kinetics of the 
PFC  response  in the  spleens of rabbits injected with  Con A  and  antigen  and 
those injected with antigen  only, precipitating  antibody levels in both groups 
peaked on day 8 (557/zg antibody/ml and 62/zg antibody/ml, respectively) and 
declined in both groups by day 13 (462/zg antibody/ml and 38 Izg antibody/ml, 
respectively). 
Effect of Irradiation  on  Cycling.  Irradiation  (500  R) of rabbits  24  h  after 
injection of 2 mg AHuIgG resulted in greatly enhanced PFC levels compared to 
rabbits injected with antigen only (Fig. 4). PFC per 106 spleen cells in irradiated 
rabbits averaged  1,355  and  1,781  on days 5 and  13,  respectively,  compared to 
PFC values of 149 and 66 on days 5 and 13, respectively, for rabbits injected with 
antigen  only.  Antibody titers on day 8 were markedly enhanced in irradiated 
rabbits injected with AHuIgG (494 /~g antibody/ml) when compared to rabbits 
only  injected  with  AHuIgG  (61  ~g  antibody/ml).  A  cyclical  pattern  of PFC 
production occurred, although there was an average of 606 indirect PFC per 106 
spleen cells on day 8, a time when only minimal PFC are detected after injection 
of antigen  alone.  Total  splenic  PFC  were  also  enhanced  by irradiation  and 
showed a  similar pattern of cycling although only approximately half as many 
lymphocytes were recovered from spleens of irradiated rabbits on all days tested. 
Kinetics  of Splenic  PFC Response  after Intraperitoneal  Injection  of Anti- 
gen.  A cyclical pattern of splenic PFC production was found after intraperito- 
neal injection of 2 mg AHuIgG (Fig. 5). Although in this experiment no compari- 
son  was  made  with  a  similar  group  of animals  injected  intravenously,  PFC 
numbers were comparable to those observed in other experiments after intrave- 
nous injection of the same dose of AHuIgG. 
Kinetics  of Secondary  Splenic PFC Response  after Low-Dose Priming.  A 
cyclical  appearance  of splenic  PFC  was  observed in  rabbits  primed  with  an 
intravenous  injection  of 0.002  mg AHuIgG  and  injected  with  2  mg AHuIgG 
intravenously approximately 1 mo later (Fig.  6).  PFC were assayed 3,  5, 8,  11, 
and 13 days after the secondary injection and showed peak levels at both days 3 
and 11. Thus, although PFC were not assayed daily, it would appear that an 8- 
day cyclical  PFC  response  occurred.  The  primary  PFC  response  to  0.002  mg 
AHuIgG  was  similar,  although  lower than,  the  response  to  2  mg AHuIgG. 
Kinetics of PFC Response in the Draining Lymph Node after Subcutaneous CAROLE  G.  ROMBALL  AND  WILLIAM  O.  WEIGLE  501 
300 
200 
a. 
100 
*  *  AHulEG  2 
-  ~  AHuleG+Con  A  / 
// 
/ 
/ 
/ 
// 
f 
/i 
// 
Day After  injection 
Fro.  3.  Comparison  of  PFC  kinetics  in  spleens  of  rabbits  after  a  single  intravenous 
injection of 2 mg AHuIgG with, or without, a simultaneous injection of 10 mg Con A. Each 
point represents an average  of PFC values from 9 to 10 rabbits. 
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Fza.  4.  Comparison  of  PFC  kinetics  in  spleens  of  rabbits  after  a  single  intravenous 
injection  of 2  mg AHuIgG  with,  or  without,  irradiation  (500  R)  24  h  after  injection  of 
antigen.  Each point represents an average of PFC values from five rabbits. 
Injection of Antigen.  A linear increase in PFC to HuIgG was found on days 5, 
8, and 13 in the draining popliteal lymph node after subcutaneous injection of 0.2 
mg AHuIgG  into  the  hind  foot  of rabbits  (Fig.  7).  Little  or  no  precipitating 
antibody was detected  in the sera of the rabbits on any of these days.  Rabbits 
injected with 0.2  mg AHuIgG subcutaneously in the hind foot and simultane- 
ously  injected  intravenously  with  2  mg  AHuIgG  had  levels  of PFC  in  the 
popliteal  node  on  day  5  comparable  to  rabbits  injected  only  subcutaneously. 
However,  PFC  in  the  nodes 8  days  after  both subcutaneous and intravenous 
injection were suppressed compared to PFC in the nodes of rabbits injected only 
subcutaneously. Between days 8 and 13, PFC in the nodes appeared at relatively 
the same rate in both groups; however,  day 13 PFC in the nodes of rabbits in- 502  REGULATION  OF CYCLICAL  RESPONSES 
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Fzo.  5.  PFC kinetics in spleens of rabbits after a single intraperitoneal injection of 2 mg 
AHuIgG. Each point represents an average of PFC values from four rabbits. 
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FIG.  6.  PFC  kinetics in  spleens of rabbits primed with 0.002  mg AHuIgG and given a 
secondary injection of 2 mg AHuIgG approximately 1 mo later.  Each point represents an 
average of PFC values from eight to nine rabbits. 
jected subcutaneously were still twofold greater than PFC in rabbits injected 
both subcutaneously and intravenously. 
Discussion 
Various mechanisms have been proposed for the regulation of physiological 
responses in which the controlling factors are generated during the response. In 
some  immunological systems,  regulation  has  been  reported  to  occur  via  a 
feedback mechanism involving circulating antibody  (22). In  other  systems, 
activation of a  regulatory population of T cells has been proposed (23). Self- 
regulation by the immune system is apparently involved in the cyclical antibody 
response to persisting antigens. In the present system, the preciseness of the 
regulation is such that successive peaks of PFC appear in the spleens of rabbits CAROLE  G. 
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FIG.  7.  PFC kinetics in the popliteal node and kinetics of serum antibody (Ab) production 
in rabbits after subcutaneous (s.c.) injection in the hind foot of 0.2 mg AHuIgG with,  or 
without, a simultaneous intravenous (i.v.) injection of 2 mg AHuIgG. Each point represents 
an average of PFC values from 10 rabbits and an average antibody titer from 5 rabbits. 
at  exact  intervals  of  8  days  after  the  initial  peak  of  PFC,  after  a  single 
intravenous injection of AHuIgG. 
The effects of mitogens on the cyclical antibody response to AHuIgG, either in 
enhancing  the  initial  and/or  succeeding  peaks  of PFC  or  in  disrupting  the 
periodic variations in the response, have been studied in an attempt to correlate 
these  effects with the  known  cellular  sites of action  of the  mitogens.  In  this 
regard,  the effect of LPS in enhancing the splenic PFC response to AHuIgG in 
rabbits is consistent with the possibility that enhancement of the response is due 
to the ability of LPS to act as a mitogen for B cells. LPS has been shown to be a 
mitogen for B cells in the mouse (24) and, although less potent, for B cells in the 
rabbit (25, 26). Furthermore,  a correlation has been demonstrated between the 
mitogenic and adjuvant activities of LPS (27). Thus, LPS may act to enhance the 
initial  peak  of PFC  by providing  a  "second  signal"  to  B  cells  (28),  thereby 
allowing low avidity precursors to receive sufficient triggering to become PFC. 
Injection of LPS with AHuIgG, however, does not result in enhancement of the 
second peak of PFC. Although LPS persists for prolonged periods of time (29), its 
failure  to  enhance  the  latter  PFC  response  may  be  due  to  the  differential 
localization  of AHuIgG and LPS, resulting in the inability of LPS to function 
effectively with  antigen  in  the  restimulation  of cells.  Thus,  only those  cells 
capable of being restimulated by persisting levels of antigen alone would partici- 
pate in the succeeding peaks of PFC. In support of this, a strict time relationship 
between  injection  of LPS  and  the  antigen  has  previously  been  shown  to  be 
necessary in order for LPS to exert its adjuvant effect (30). It is unlikely that the 
failure of enhanced PFC in the second peak is due to suppression by high levels 
of antibody since either PHA or irradiation likewise enhance antibody synthesis 
while also enhancing the second peak. Although the above model is compatible 
with  the  experimental  results,  LPS does affect a  variety  of physiological re- 504  REGULATION  OF CYCLICAL  RESPONSES 
sponses, any of which could also be responsible, at least in part, for these effects. 
Indeed, effects of LPS on other cells directly involved in the immune response, 
i.e. T cells and macrophages, have also been reported (31-33). 
In contrast to LPS, activation of a T-cell helper population could explain the 
enhancement of both the initial and succeeding peaks of PFC observed when 
PHA is injected with AHuIgG. Once the T-cell population has been expanded, 
these T cells would be available for cooperation with competent B cells, resulting 
in triggering of a larger population of specific B cells. A similar stimulation has 
been observed in vivo in mice (34). However, PHA has been shown to suppress, 
not  enhance  the  in  vitro  response  of mouse  spleen  cells  (35). Since  a  strict 
comparison has not been made in the mouse between in vivo and in vitro effects 
of PHA on the PFC response to a particular antigen, it is possible that PHA acts 
via different mechanisms under in vivo and in vitro conditions. Furthermore, 
although PHA has been shown to be a mitogen for a subpopulation of T cells in 
both mice (36) and rabbits (25, 37), and there appears to be a similarity in the 
function of different cell types in the mouse and rabbit (38), subtle differences 
have  become  apparent  (39) which  might result  in  PHA  acting via  different 
mechanisms in the mouse and rabbit.  In addition, an in vivo effect of PHA in 
stimulating B cells directly cannot be ruled out since PHA also binds to B cells 
in the mouse (40) and is capable of stimulating B cells in vitro under conditions 
in which it is locally concentrated (41). However, if PHA enhances the response 
by stimulating B cells, it does so differently  than LPS, since only the initial peak 
of PFC  is  enhanced by  LPS,  but  both  the  initial  and  succeeding peaks  are 
enhanced by  PHA.  Neither  mitogen,  however,  has  an  effect on  the  precise 
timing of the cyclical appearance of PFC. 
Activation of a helper population of T cells by Con A is also compatible with 
the enhancement of the immune response to AHuIgG by this mitogen. However, 
additional  events  must  also  occur  after  injection  of Con  A  since  a  marked 
disruption of the cyclical response occurs, resulting in a linear increase in PFC 
over the 13-day period assayed. Con A has been shown to activate both helper 
and  suppressor  populations of mouse lymphocytes in  vitro depending on the 
conditions of  culture (35). Similarly, activation ofT cells by Con A could result in 
an alteration of the regulatory balance between helper and suppressor popula- 
tions of T cells normally present in vivo after antigen activation. The decreased 
response observed five days after injection of AHuIgG and Con A as compared to 
injection of AHuIgG  alone  might be  due  to  the  preferential  activation of a 
nonspecific suppressor cell population by Con A.  A  similar early suppression 
followed by subsequent enhancement was observed in the response of rabbits to 
sheep  erythrocytes (14). Such early activation of suppressor  cells could then 
exhaust this population so that specific activation of suppressor cells by antigen 
would  not  ' occur  later  in  the  response.  Expression  of helper  or  suppressor 
function after injection of AHuIgG alone  may be,  in  part,  mediated by the 
amount of functional antigen available (42). In any event, both of the putative 
suppressor effects observed in this system are short-lived, a characteristic of the 
suppressive effects found in other systems (43, 44). However, again, alternative 
mechanisms are possible for the regulation of the AHuIgG response by Con A. 
As with PHA, Con A also binds to B cells (40) and is capable of stimulating them CAROLE  G.  ROMBALL  AND  WILLIAM  O.  WEIGLE  505 
when locally concentrated (45). Secondly, Con A has been shown to alter the 
migration of cells,  in  that  mouse  lymphocytes treated  in  vitro  with  Con  A 
preferentially migrate to the spleens of normal syngeneic recipients (46). How- 
ever, differential migration of cells would not appear to explain the effect of Con 
A on this system since the kinetics of appearance of PFC in the peripheral blood 
after injection of Con A with antigen were altered in a  similar manner as the 
kinetics of appearance of PFC in the spleen. Also, PFC in the mesenteric nodes 
showed an increase in numbers between days 5 and 8 when Con A was injected 
simultaneously with AHuIgG. PFC in the mesenteric nodes showed no further 
increase  on  day  13,  but  it  has  previously been  shown  that  antigen  is  only 
retained  in  the  node  for  a  short  period  of time  and  cannot  be  observed  in 
autoradiographs of sections of nodes on day 10, at a time when labeled antigen 
can be seen in the spleen (4). That PFC do not increase in the mesenteric nodes 
between days 8 and 13 can therefore be attributed to the lack of antigen in this 
organ.  Thus  all  lymphoid organs  examined--spleen,  mesenteric  node,  and 
peripheral bloodmshowed an alteration of the appearance of PFC after injection 
of Con A  with AHuIgG as compared to injection of AHuIgG alone.  However, 
despite the continued increase in antibody-forming cells in these organs,  the 
kinetics of appearance of circulating antibody did not differ in animals injected 
only with antigen or with Con A and antigen, although antibody levels were 
markedly enhanced in rabbits injected with Con A. Thus, although PFC levels 
maintained  a  constant  increase  between  days  5  and  13  in  the  spleen  and 
peripheral  blood  of rabbits  injected  with  Con  A  and  AHuIgG,  the  levels  of 
circulating antibody declined slightly by day 13,  at a  rate  similar to that in 
rabbits injected only with AHuIgG, in which PFC on day 8 were negligible. It 
remains to  be  determined whether this  difference reflects a  decrease  in  the 
amount of antibody secreted by cells late in the response after injection of Con A 
with AHuIgG, early production of more avid antibody, or a  relatively greater 
contribution by mesenteric node PFC to the circulating antibody pool.  Regard- 
less, it would be difficult to explain the cyclical appearance of PFC on the basis 
of regulation by circulating antibody since PFC increase during a period when 
circulating antibody levels are high. 
The enhancing effect of irradiation 24 h  after injection of AHuIgG could be 
explained by elimination of suppressor cells, a subpopulation of T cells reported 
to be relatively radiosensitive (47). Thus, the enhanced levels of PFC could be 
due to elimination of cells which, in the normal animal, are capable of limiting 
the immune response.  This effect has been observed with many antigens and 
has previously been considered a result of more space made available in lymph- 
oid organs for division of specifically stimulated cells (16). However, although 
markedly greater numbers of PFC are observed in the interval between days 5 
and 13 in rabbits injected with antigen and irradiated, compared to those only 
injected with antigen, a definite cyclical response is still apparent after irradia- 
tion. Thus, it would be attractive to consider two suppressor populations of  cells, 
one regulating the  quantity of antibody produced,  the second regulating the 
turn-on or shutoff of antibody production. 
The capacity of splenic lymphocytes to exhibit a cyclical response to AHuIgG 
is not limited to an intravenous injection, nor is it limited to a primary response. 506  REGULATION  OF CYCLICAL  RESPONSES 
Intraperitoneal  injection  of antigen  resulted  in a  cyclical appearance  of PFC 
practically  identical  to  that  observed  after  intravenous  injection  of antigen. 
Cycling was also observed in the secondary response to 2 mg AHuIgG when the 
priming dose was 0.002 mg. Previously, only a single peak of PFC was observed 
in  the  secondary  response  to  an  intravenous  injection  of 2  mg  AHuIgG  in 
animals primed with 2 mg AHuIgG (4). Since PFC were observed in the primary 
response after injection  of both 0.002  mg and 2 mg AHuIgG, the absence of a 
cyclical response with the  latter  dose cannot be attributed  to the presence  of 
primed,  rather  than  virgin  B  cells,  unless  the  effect  is  due  to  quantitative 
differences. 
The exquisiteness of the regulation of the immune response by the lymphoid 
system is illustrated  by the regulation  of the response in the popliteal  lymph 
node as the result of an injection which stimulates the spleen.  After subcuta- 
neous injection of AHuIgG in the hind foot, the PFC response in the draining 
popliteal node increased linearly throughout a  13-day time period. However, if, 
in addition to subcutaneous injection, the antigen was also given intravenously, 
a  normal cyclical PFC response was observed in the spleen.  Furthermore,  the 
PFC  in  the  node  on  day  8  were  depressed  in  rabbits  injected  with  antigen 
subcutaneously and intravenously compared to the response in rabbits receiving 
only the subcutaneous injection. Recovery of the PFC response in the node was 
apparent on day 13 in rabbits injected subcutaneously and intravenously. Thus, 
the  suppression  of the  popliteal  node  response  in  rabbits  by  simultaneous 
intravenous injection of AHuIgG could be the result of suppressor cells activated 
in  the  spleen  which  then  circulate  to  the  node.  Since  measurable  levels  of 
circulating  antibody  were  produced  after  intravenous,  but  not  subcutaneous 
injection, this shutoff could also be mediated by circulating  antibody produced 
by PFC stimulated in the spleen and mesenteric nodes as a result of intravenous 
injection.  However, this possibility seems unlikely since,  after an intravenous 
injection  of AHuIgG,  not only is there  no correlation  between the  amount  of 
antibody  formed  and  the  time  of appearance  of peak  PFC,  but  the  time  of 
appearance  and  disappearance  of  antibody  is  the  same  whether  a  cyclical 
pattern  of PFC production exists (AHuIgG injection) or does not exist (Con A 
and AHuIgG injection). Furthermore,  circulating antibody levels after injection 
of Con A with AHuIgG are extraordinarily  high during a  time when PFC are 
increasing linearly. 
It is tempting to postulate that lymphocytes in the node are being regulated 
by  suppressor  T  cells  activated  in  the  spleen  as  the  result  of intravenous 
injection  of AHuIgG.  A  similar  regulatory  role  of spleen-localizing  parental 
thymocytes on the  DNA synthetic response of lymphocytes in the nodes of F, 
recipients has been described by Gershon et al. (48). Although these regulatory 
T cells were shown to preferentially localize in the spleen, antigenic stimulation 
may result in changes in the spleen and nodes, allowing these cells to exit from 
the spleen and migrate to the node. Indeed, antigenic stimulation of the lymph 
node  has  been  shown  to  result  in  expansion  of postcapillary  venules  in  the 
nodes, making them permeable to normally nonmigratory cells (C. Metzler and 
R. Gershon, personal communication),  as has been shown for sites involved in 
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The biological role for such precisely controlled regulation is as yet unclear. 
However, striking examples exist as in the case of patients immunized with Rh 1 
by transfusion or pregnancy who have exhibited 7-day periodical variations in 
anti-Rh 1 production for as long as 40 yr after immunization (50). Whatever the 
mechanism involved in these regulatory phenomena, the spleen appears to play 
a  major role. 
Summary 
Modulation of the cyclical response in rabbits to aggregated human gamma 
globulin (AHuIgG) was investigated in order to study some of the parameters 
involved in self-regulation of the immune response. Several mitogens (lipopoly- 
saccharide  [LPS],  phytohemagglutinin  [PHA],  and  concanavalin  A  [Con A]), 
when injected simultaneously with antigen,  have been shown to modulate the 
normal splenic plaque-forming cell (PFC) response in rabbits to a single intrave- 
nous injection of AHuIgG. This response to AHuIgG has previously been charac- 
terized by the initial appearance of PFC in the spleen 3 days later, with a peak of 
PFC at 5 days after injection.  The number of PFC in the spleen then decreases 
and remains at a low level until a second increase begins on day 10, peaking on 
day 13. The 8-day cycle between peak PFC repeats, with a third peak appearing 
on day 21. In the present studies, injection of LPS with AHuIgG was shown to 
affect the PFC response by enhancing  only the initial  peak of PFC, PHA was 
shown to enhance both the initial and secondary peaks of PFC, while injection of 
Con A with AHuIgG resulted in a  prolonged increase in PFC with no apparent 
cycling.  Irradiation  24  h  after  injection  of antigen  resulted  in  PFC  kinetics 
similar  to those observed with PHA, although  the increase  in PFC was more 
marked  with irradiation.  Thus,  although  LPS,  PHA,  Con A,  and  irradiation 
markedly  affected  the  immune  response  to  AHuIgG,  Con  A  was  the  only 
substance which altered the cyclical appearance of PFC to HuIgG. The cyclical 
nature  of the  PFC  kinetics  was  shown  to  occur  with  either  intravenous  or 
intraperitoneal  injection  of antigen  and  in  both  primary  and  secondary  re- 
sponses, provided that the rabbits were primed with a  low dose of antigen. 
Data were obtained that suggest that the response in distal lymph nodes may 
be regulated by immunological events occurring in the spleen.  Cycling of PFC 
was not observed in the draining node after subcutaneous injection of AHuIgG 
in the hind foot. However, if the antigen was also injected intravenously at the 
same  time  as  the  subcutaneous  injection,  the  response  in  the  node  became 
cyclical. 
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